|MYOK -- USA Stock|| |
USD 56.80 1.15 2.07%
We currently do not have informatin regarding Leslie Leinwand. This executive tanure with MyoKardia is not currenlty determined.
The company has return on total asset (ROA)
of (14.21) %
which means that it has lost $14.21 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (27.81) %
meaning that it created substantial loss on money invested by shareholders.
MyoKardia, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of rare cardiovascular diseases. MyoKardia, Inc. was founded in 2012 and is headquartered in South San Francisco, California. MyoKardia operates under Biotechnology classification in USA and traded on BATS Exchange. It employs 120 people.MyoKardia (MYOK) is traded on BATS Exchange in USA. It is located in CALIFORNIA U.S.A and employs 120 people. MyoKardia is listed under Pharmaceutical Products category by Fama And French industry classification.
MyoKardia Leadership Team
|Eric Topol, Independent Director|
|Sunil Agarwal, Independent Director|
|Christine MD, Co-Founder|
|Taylor Harris, CFO|
|Mark Perry, Independent Director|
|June Lee, COO|
|Wendy Yarno, Independent Director|
|Kevin Starr, Director|
|Jake Bauer, Vice President - Business Development and Business Operations|
|Joseph Lambing, Senior Vice President - Nonclinical and Pharmaceutical Development|
|Steven Chan, Vice President Corporate Controller|
|Mary Cranston, Director|
|Katherine Bowdish, Director|
|Robert McDowell, Sr. VP of Drug Discovery|
|David Meeker, Independent Director|
|Marc Semigran, Chief Medical Officer|
|Leslie Leinwand, Co-Founder|
|Tassos Gianakakos, CEO and President and Director|
|Charles Homcy, Director|
|Jonathan Fox, Chief Medical Officer|
|Kimberly Popovits, Independent Director|
Stock Performance Indicators
Most of Macroaxis users are now bullish on MyoKardia. What is your trading attitude regarding investing in MyoKardia? Are you bullish or bearish?
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see also Stocks Correlation
. Please also try Global Markets Map
module to get a quick overview of global market snapshot using zoomable world map. drill down to check world indexes.